Michael Weisman

1/ Just published in @IJROBP: “Histological Classifier of Radiosensitivity to Spine SBRT.” doi.org/10.1016/j.ijro…

US gov / DOE is posting about radiopharmaceuticals and alpha therapy! @freddyeescorcia #radonc

Very grateful to present at @NRGonc today with Dr. Sara Hardy of @uwradonc as study co-chairs of the new NRG-CC017 multicenter RCT examining Temporally Modulated Pulsed Radiation Therapy (#TMPRT) for #GBM led by national PI Dr. Jiayi Huang of @SitemanCenter! #RadOnc #NRG2025

1/14 When I was 14 years old, soccer was everything to me. I wasn’t the best player, but I prided myself on my endurance. In the fall of 2005, I started becoming winded very easily.

New in #practicalRO: Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice Guideline. #radonc tinyurl.com/probovi

Our newest CAPRI trial, called PREVENT, is a phase II/III RCT testing high dose palliative RT for NSCLC to dose of 35/5, with esophageal sparing. 🇨🇦 We hope this will improve survival and QOL. Congrats @goodmanC_MD for getting this off the ground! ⬇️⬇️⬇️

Congratulations to DCI's Nicole Larrier, MD, on being named a 2025 @ASTRO_org fellow! This designation has been awarded to 541 of ASTRO’s 10,000 members worldwide since its inception in 2006. duke.is/c/euhp @DukeMedSchool | @DukeRadOnc

Congratulations! This is an amazing class of @ASTRO_org Fellows

Very honored to be the 2025 @NationalMedAssn Spotlight on Initiatives Promoting Access to Care #RadOnc keynote speaker discussing origins & progress of #PatientNavigation & the Navigator-Assisted Hypofractionation (#NAVAH) program! #bcsm #pcsm #RepresentationMatters #NMAChicago25

My daughter Emma has continued to make art this summer and, for the month of July, is donating 50% of the proceeds from her website to flood relief in Texas (specifically the Texas Children's Central Texas Hope Fund) Links here: artfromtheheartut.squarespace.com/all-prints texaschildrens.org/content/our-he…

A very interesting and enjoyable article to read on @NatRevClinOncol (doi.org/10.1038/s41571…) which takes stock of the complex mechanisms of interaction between the microbiota and radiotherapy #radonc. It may seem strange and counter-intuitive, but 1 Gy of radiotherapy targeting…

Excited to share our experience (largest so far) using Boswellia for radiation necrosis with brain mets. ORR 60%, median duration 14 months. Amazing responses and a game changer for patients, I highly recommend you check it out!!! pubmed.ncbi.nlm.nih.gov/39993542/ redjournal.org/article/S0360-…

🧵 ABR Oral Board Exam Update On Monday, July 14, @ABR_Radiology leadership met with stakeholders from the @ASTRO_org community to discuss the oral board exam process. It was a productive and collaborative session. #RadOnc 1/5

Proud to share our @ESTRO_RT manifesto published in @RO_GreenJournal A call to reposition radiation oncology at the heart of integrated cancer care Open access for 50 days authors.elsevier.com/a/1lRcWcA0-MUMK #RadOnc #ESTRO #OncoAlert @OncoAlert sciencedirect.com/science/articl…

Remarkable response to Boswellia after necrosis due to high dose brain SRS. In case you didn’t know I am a strong advocate for Boswellia we should all be using this!!! advancesradonc.org/article/S2452-…

Expanding the Scope of Radiation Therapy for Nonmalignant Diseases | ASTRO If you are looking for a tour de force on this topic, then look no further. This course is a low-cost, high-yield review on the topic led by the global experts 1/2 academy.astro.org/content/expand…

I learned this week that SABR-COMET patient #1 recently passed away, more than 12 years after enrollment, with no recurrence since his original SABR. We initially treated him for a left adrenal met. It’s an interesting story… ⬇️⬇️⬇️

#radonc sciencedirect.com/science/articl… Thanks to Dr. Chhabra, and team for spearheading this important discussion. And thanks to the usual suspects that speak up for the health of the field and young doctors. @DrChowdharyMD, @CShahMD, @JamesBatesMD